ArticleFrontiers in oncology2026
Esophageal submucosal gland duct adenoma: a case report and pooled analysis of demographic differences between eastern and western populations.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Esophageal submucosal gland duct adenoma (ESGDA) is an exceptionally rare benign tumor. Classic teaching suggests a predilection for the upper and mid esophagus. This study reports a new case and performs a comparative literature analysis to test for potential geographic variations. Case introduction: A 61-year-old Asian male was found to have a 1.6 cm submucosal tumor in the distal esophagus during a routine check-up. The lesion was successfully resected via endoscopic submucosal dissection (ESD), with pathological confirmation of ESGDA. Methods: We conducted a pooled analysis of 20 well-documented ESGDA cases from the literature. Cases were stratified into an Eastern cohort (n=10) and a Western cohort (n=10) based on the first author's affiliation. Demographic and tumor characteristics were systematically compared. Given the small sample size, Fisher's exact test was applied for categorical variable comparisons. Results: Striking differences were observed. The Eastern cohort exhibited a profound male predominance (9:1 male-to-female ratio), whereas the Western cohort had a balanced sex distribution (1:1). Fisher's exact test for this comparison yielded a two-sided P value of 0.141. Tumor location also differed dramatically: 100% of Eastern cases were located in the distal esophagus/gastroesophageal junction, compared to only 40% of Western cases, with 60% of Western cases found in the mid or upper esophagus, a pattern not seen in the Eastern cohort (Fisher's exact test, P = 0.011). Mean age and tumor size were similar between groups. Conclusion: The clinical presentation of ESGDA demonstrates notable geographic patterns. In this analysis, Eastern cases presented exclusively in the distal esophagus with a strong male predominance, while Western cases showed a broader anatomical distribution and a balanced sex ratio. These descriptive findings suggest potential population-specific differences. Clinicians should be aware of these patterns, and future studies with larger sample sizes are warranted for confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.